Wuhan Children's Hospital

This study tested whether rituximab, an antibody treatment, works better than tacrolimus, a standard medication, to reduce relapses in children with a challenging form of kidney disease called steroid-sensitive nephrotic syndrome. Ninety-one children received one of the two treat…